Stem Cells
Revolutionizing Medicine
Innovators in Stem Cell Research
CIRM’s objective is to help fund the development of stem cell research by providing funding in California. It was created in 2004, when Proposition 71: the California Stem Cell Research and Cures Initiative was passed. CIRM also strives to get more scientists into the stem cell field and focuses on training young scientists. It has contributed to the development of new facilities and provides training opportunities for high school, undergraduate, and graduate students in regenerative medicine.
“CIRM funding promotes all areas of stem cell research that show promise to accelerating treatments to patients in need.”
U.S. Stem Cell studies a wide range of potential stem cell therapies and collaborates with other stem cell institutes with the objective of developing new treatments and alleviating patients. Currently, the company is focused on MyoCell®, a muscle stem cell therapy, that hopes to improve cardiac function in chronic heart failure patients.
“The future of medicine lies in understanding how the body creates itself out of a single cell and the mechanisms by which it renews itself throughout life.”
Established in 2002, Stanford Institute for Stem Cell Biology and Regenerative Medicine was established to expand Stanford’s leadership in stem cell research. It is managed by Irving Weissman, a leading expert in cancer stem cell biology and renowned “father of hematopoiesis” The institute is also focused on cultivating the next generation of stem cell scientists through its affiliation with the Stanford Medical School.
Irving Weissman explains the discoveries in the blood cancers by the Stanford Institute for Stem Cell Biology and Regenerative Medicine. He reveals the importance of collaboration between research labs and CIRM, which provides funding for these discoveries.